Gary Gaglione
2017
In 2017, Gary Gaglione earned a total compensation of $543.8K as Former Chief Financial Officer at Matinas BioPharma Holdings.
Compensation breakdown
| Bonus | $50,000 |
|---|---|
| Option Awards | $275,463 |
| Salary | $218,333 |
| Total | $543,796 |
Gaglione received $275.5K in option awards, accounting for 51% of the total pay in 2017.
Gaglione also received $50K in bonus and $218.3K in salary.
Rankings
In 2017, Gary Gaglione's compensation ranked 11,552nd out of 14,666 executives tracked by ExecPay. In other words, Gaglione earned more than 21.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,552 out of 14,666 | 21st |
Division Manufacturing | 4,527 out of 5,768 | 22nd |
Major group Chemicals And Allied Products | 1,654 out of 2,074 | 20th |
Industry group Drugs | 1,368 out of 1,730 | 21st |
Industry Pharmaceutical Preparations | 1,066 out of 1,329 | 20th |
Source: SEC filing on September 24, 2019.
Gaglione's colleagues
We found four more compensation records of executives who worked with Gary Gaglione at Matinas BioPharma Holdings in 2017.
2017
Roelof Rongen
Matinas BioPharma Holdings
Chief Executive Officer
2017
Jerome Jabbour
Matinas BioPharma Holdings
Chief Executive Officer
2017
Dominick DiPaolo
Matinas BioPharma Holdings
Former Senior Vice President, Quality and Regulatory Compliance
2017
Raphael Mannino
Matinas BioPharma Holdings